We are live on
!
Find out more
Ultragenyx Pharmaceutical
RARE
RARE
173 hedge funds and large institutions have $2.67B invested in Ultragenyx Pharmaceutical in 2020 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 69 increasing their positions, 46 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 46
21% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 24
7% more capital invested
Capital invested by funds: $2.49B → $2.67B (+$185M)
3.12% more ownership
Funds ownership: 100.88% → 104% (+3.1%)
9% more call options, than puts
Call options by funds: $13.4M | Put options by funds: $12.3M
1% more funds holding
Funds holding: 172 → 173 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
173
Holders Change
+1
Holders Change %
+0.58%
% of All Funds
3.81%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
29
Increased
69
Reduced
46
Closed
24
Calls
$13.4M
Puts
$12.3M
Net Calls
+$1.06M
Net Calls Change
+$11.6M
Top Buyers
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$54.2M |
| 2 |
Bank of New York Mellon
New York
|
+$24.6M |
| 3 |
Alkeon Capital Management
New York
|
+$12.5M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$11.3M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$11M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$23.2M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
-$13.3M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
-$12.5M |
| 4 |
BlackRock
New York
|
-$8.8M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$6.98M |
